BeOne Medicines (ONC) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.37% |
| Dec 31, 2025 | -12.65% |
| Sep 30, 2025 | -46.47% |
| Jun 30, 2025 | -9.52% |
| Mar 31, 2025 | 4.22% |
| Dec 31, 2024 | 2.76% |
| Sep 30, 2024 | -4.21% |
| Jun 30, 2024 | 7.19% |
| Mar 31, 2024 | 12.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 9.72% |
| Jun 30, 2023 | 8.26% |
| Mar 31, 2023 | 15.48% |
| Dec 31, 2022 | -419.93% |
| Sep 30, 2022 | 84.71% |
| Jun 30, 2022 | -200.49% |
| Mar 31, 2022 | 15.35% |
| Dec 31, 2021 | 42.75% |
| Sep 30, 2021 | 10.61% |
| Jun 30, 2021 | -50.54% |
| Mar 31, 2021 | 37.41% |
| Dec 31, 2020 | 1.03% |
| Sep 30, 2020 | -161.38% |
| Jun 30, 2020 | -28.18% |
| Mar 31, 2020 | -45.10% |
| Dec 31, 2019 | -158.25% |
| Sep 30, 2019 | 39.24% |
| Jun 30, 2019 | 27.54% |
| Mar 31, 2019 | 20.44% |
| Dec 31, 2018 | 23.22% |
| Sep 30, 2018 | -2.63% |
| Jun 30, 2018 | -38.88% |
| Mar 31, 2018 | -18.64% |
| Dec 31, 2017 | -10.77% |
| Sep 30, 2017 | -89.08% |
| Jun 30, 2017 | -20.01% |
| Mar 31, 2017 | 11.05% |
| Dec 31, 2016 | -80.82% |
| Sep 30, 2016 | 10.15% |
| Jun 30, 2016 | 8.34% |
| Mar 31, 2016 | -146.03% |
| Dec 31, 2015 | -266.07% |
| Sep 30, 2015 | -9.12% |
| Jun 30, 2015 | -88.19% |